reports
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® ...
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that additional data supporting IBSRELA® (tenapanor) will be presented at the 2024 Digestive Disease Week Conference (DDW), to be held May 18-2...
Mainz Biomed to Present Results of Colorectal Cancer Screening Study e...
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C. The eAArly DETECT results reported a sensitivity for colorectal cancer of 97% with a specificity of 97% and a sensitivity for advanced adenoma of 82% BERKELEY, Calif. and MAINZ, Germany, May 07, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, will present an analysis from its eAArly DETECT study at Digestive Disease Week (DDW) 2024 in Washington D.C. from May ...
Zscaler Joins Forces with Google to Offer Unparalleled Zero Trust Data...
Zscaler Joins Forces with Google to Offer Unparalleled Zero Trust Data and Threat Protection Enterprises can now Ensure Secure, Remote Access to Private Web Apps across devices and locations with Zscaler and Google Chrome Enterprise SAN JOSE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ZS), the leader in cloud security, has collaborated with Google on a joint zero trust architecture with Chrome Enterprise. This powerful combination brings the power of Zscaler Private Access™ (ZPA) enabling zero trust secure access to private applications to anyone across different locations and d...
Great Lakes Reports First Quarter 2024 Results
Great Lakes Reports First Quarter 2024 Results First quarter net income of $21.0 millionFirst quarter adjusted EBITDA of $42.9 millionDredging backlog of $879.4 million at March 31, 2024 HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation (“Great Lakes” or the “Company”) (Nasdaq: GLDD), the largest provider of dredging services in the United States, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Revenue was $198.7 millionTotal operating profit was $31.5 millionNet income was $21.0 millionAdjusted ...
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and...
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights Encouraging preliminary data announced from the NXP800 Phase 1b study in platinum resistant, ARID1a-mutated ovarian cancer, a program granted Fast Track Designation by the US FDAData presented at the 2024 AACR demonstrate NXP900's robust activity in non-small cell cancer cell linesSeveral clinical data updates expected in 2H 2024 FORT LEE, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focus...
Alphawave IP Group: 1 director
A director at Alphawave IP Group maiden bought 100,000 shares at 117p and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleo...
Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presentations at the ASGCT Annual Meeting BEDMINSTER, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces that , will be presenting two abstracts at the being held May 7-11, 2024 in Baltimore highlighting data from ex vivo, in vitro and in vivo studies evaluating the use of Matinas’ LNC platform for the uptake ...
Liquidia Corporation to Report First Quarter 2024 Financial Results on...
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024 MORRISVILLE, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its first quarter 2024 financial results on May 14, 2024. The company will host a live webcast at 8:30 a.m. Eastern Time to discuss financial results and provide a corporate update. The live webcast will be available on Liquidia's website at . A rebroadcast of the event will be available and archived for a period of one year at the same location.About Liquidia CorporationLiquidia Cor...
Talkspace Announces First Quarter 2024 Results
Talkspace Announces First Quarter 2024 Results 1Q 2024 Total revenue grew 36% year-over-year 1Q 2024 Payor revenue grew 92% year-over-year Reduced GAAP Net loss to $1.5 million from $8.8 million year-over-year Delivers first profitable quarter with Adjusted EBITDA1 of $0.8 million NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: TALK), today reported first quarter 2024 financial results. Three Months Three Months Ended March 31, 2024 (Unaudited) Results % Variance from Prior Year(In thousands unless otherwise noted) Number of eligible liv...
Whitestone REIT Board Leaders Issue Open Letter to Shareholders
Whitestone REIT Board Leaders Issue Open Letter to Shareholders HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today issued a shareholder letter from independent Board Chair David Taylor and Chair of the Nominating and Corporate Governance Committee, Nandita Berry. In their joint letter, Ms. Berry and Mr. Taylor detail the challenging and decisive actions they took as change agents to terminate the former CEO James Mastandrea for cause, revitalize corporate governance, and oversee the successful ongoing value creation plan under the ...
BioAtla to Announce First Quarter 2024 Financial Results and Provide B...
BioAtla to Announce First Quarter 2024 Financial Results and Provide Business Highlights on May 14, 2024 SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that it plans to host a conference call and webcast on Tuesday, May 14, 2024 at 4:30 p.m. ET to discuss its financial results for the first quarter ended March 31, 2024 and provide business highlights. Conference Call and Webcas...
Alimera Announces Scientific Data Highlighting YUTIQ® to be Presented ...
Alimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress Conferences ATLANTA, May 07, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announced today it will have three scientific abstracts at two upcoming ophthalmic congresses including the Association for Research in Vision and Ophthalmolo...
Sirona Biochem Engages Stonegate Healthcare Partners
Sirona Biochem Engages Stonegate Healthcare Partners VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) has announced a partnership with Stonegate Healthcare Partners. Stonegate is a leading corporate advisory firm based in Dallas, Texas that offers research driven business development and investor outreach services. Leveraging Stonegate’s extensive global network of corporate and institutional investor relationships, Stonegate has begun an evaluation of Sirona’s anti-aging ingredient, GlycoProteMimTM, to effectively ass...
Dayforce Releases Dayforce Partner Exchange
Dayforce Releases Dayforce Partner Exchange An open and connected marketplace to help Dayforce customers accelerate HR innovation and unlock more value MINNEAPOLIS and TORONTO, May 07, 2024 (GLOBE NEWSWIRE) -- , Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced the availability of , a curated ecosystem of software and services partners that implement and extend Dayforce solutions. Dayforce customers are now able to access fully vetted system integrators and technology providers within the Dayforce platform, helping to...
4DMT to Participate in Upcoming Investor Conference
4DMT to Participate in Upcoming Investor Conference EMERYVILLE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, today announced that management will participate in a fireside chat at an upcoming investor conference in May. Members of the management team will also be available for one-on-one meetings. Bank of America Health Care Conference 2024 Presentation Date:Tuesday, May 14, 2...
Oragenics Partners with Avance Clinical for Phase II Concussion Trial ...
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia SARASOTA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneer in developing innovative intranasal pharmaceuticals for neurological disorders, today announced a partnership with Avance Clinical, a leading Contract Research Organization (CRO), to conduct a Phase II clinical trial in Australia. This trial aims to evaluate Oragenics' lead drug candidate, ONP-002, for mild Traumatic Brain Injury (TBI), commonly known as concussion. ONP-002, a novel chemical entity (NCE), is de...
Daré Bioscience to Host First Quarter 2024 Financial Results and Compa...
Daré Bioscience to Host First Quarter 2024 Financial Results and Company Update Conference Call and Webcast on May 14, 2024 SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Tuesday, May 14, 2024, to review its financial results for the quarter ended March 31, 2024 and to provide a company update. To access the conference call via phone, dial (646) 307-1963 (U.S.) or (800) 715-9871 (toll free). The conference ID number fo...
Aspira Women’s Health Announces Publication of Two OvaWatch Peer-Revie...
Aspira Women’s Health Announces Publication of Two OvaWatch Peer-Reviewed Manuscripts AUSTIN, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the publication of two peer-reviewed manuscripts. The first manuscript, entitled “” was published in the peer-reviewed journal Frontiers of Medicine on May 2, 2024. The findings of this study demonstrate that use of OvaWatch® to stratify risk in patients with ...
VPN Risk Report Finds More Than Half of Organizations Experienced a VP...
VPN Risk Report Finds More Than Half of Organizations Experienced a VPN-related Cyberattack in the Last Year Zscaler ThreatLabz 2024 annual report reveals 78% of organizations plan to implement a Zero Trust strategy in the next 12 months in response to increasing exploits VPN security concerns rise as 91% of respondents express concerns about VPNs leading to a compromising breachThe survey identifies the top threats exploiting VPN vulnerabilities to be ransomware (42%), other types of malware (35%), and DDoS attacks (30%)Lateral movement is a top concern, as reported by a majority of ente...
Phunware Appoints Hospitality Industry Veteran as Strategic Advisor to...
Phunware Appoints Hospitality Industry Veteran as Strategic Advisor to Propel Hospitality Sector Growth Seasoned Hospitality Leader Paul Ruffino Joins Phunware, Bringing Over Four Decades of Industry Expertise AUSTIN, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: PHUN) (the “Company”), the leading provider of patented wayfinding and mobile engagement solutions that enable brands to engage, manage and monetize anyone anywhere, announced that hospitality industry veteran Paul Ruffino has been appointed as a Strategic Advisor to guide Phunware’s hospitality offering, effective May 7, 2...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.